YouthBio Therapeutics unveils its board, with João Pedro de Magalhães as CSO
CISION PR Newswire - 14-Apr-2022Another company enters the cellular reprogramming race - hopefully at least one will cross the finishing line
Join the club for FREE to access the whole archive and other member benefits.
Co-founder and CFO at YouthBio Therapeutics and General Partner/ Fund Manager at Inception Capital
Viet is an angel investor and entrepreneur with over twenty years of fund management, trading, equities analysis, market forecasting, and business development experience. He is a recipient of the 2016 Wealth & Finance International U.S. Venture Capital Fund Manager of the Year Award.
Viet has researched and invested in biotech companies since 2004 and helped build and presently serves as a strategic adviser to Genprex, a gene therapy biotech company. He has also been an early investor in Airbnb, SpaceX, and Virgin Hyperloop.
Viet is passionate about the global markets, building businesses, emerging technology and cancer biotech.
Visit website: https://youthbiotx.com/#viet
See also: YouthBio Therapeutics - Developing rejuvenation gene therapies based on partial reprogramming by Yamanaka factors
Details last updated 15-Apr-2022
Developing rejuvenation gene therapies based on partial reprogramming by Yamanaka factors
Another company enters the cellular reprogramming race - hopefully at least one will cross the finishing line